Pharma & Biotech

Amicus Therapeutics has achieved a significant financial turning point, reporting its first GAAP-profitability alongside substantial revenue growth. The biotechnology firm's...

The competitive landscape for anti-obesity medications has been jolted by a significant development from Viking Therapeutics. The biopharmaceutical company announced...

The Danish pharmaceutical giant, once Europe's most valuable company, now faces a critical inflection point. In a dramatic strategic pivot,...

The biotech sector is known for its volatility, but Assembly Biosciences is currently demonstrating remarkable strength. Building on a year...

The animal health sector's leading company, Zoetis, finds itself mired in an extended decline. Market experts are systematically lowering their...

Healwell AI positions itself as a technological pioneer deploying artificial intelligence within the healthcare sector. However, this vision is currently...

The laboratory equipment giant finds itself navigating a classic market dilemma. While quarterly results have surpassed expectations and a massive...

A significant milestone has been reached by InnoCan Pharma, moving beyond speculative potential to deliver concrete scientific evidence. The recent...

Eli Lilly, currently a dominant force in the pharmaceutical sector largely due to the success of its weight-loss medications, is...

Biotechnology firm Ocugen finds itself at a critical juncture. With its shares under significant pressure, CEO Dr. Shankar Musunuri is...